Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dr Agarwal'S Eye HospitalBOM:526783 +0.93%94 EV-to-EBIT is 24.63 as of Aug. 30, 2026, which is 69% above its 10-year median of 14.57. GuruFocus rates BOM:526783 with a GF Score™ of 94/100 and a GF Value™ of ₹5,531.87 (Fairly Valued). The stock has 3 warning signs investors should review. Among 477 Healthcare Providers & Services companies, Dr Agarwal'S Eye Hospital ranks worse than 72.33% on this metric.
The historical rank and industry rank for Dr Agarwal'S Eye Hospital's EV-to-EBIT or its related term are showing as below:
BOM:526783'
s EV-to-EBIT Range Over the Past 10 Years
Min: 3.44 Med: 14.57 Max: 45.08
Current: 24.63
During the past 13 years, the highest EV-to-EBIT of Dr Agarwal'S Eye Hospital was 45.08. The lowest was 3.44. And the median was 14.57.
BOM:526783's EV-to-EBIT is ranked worse than 72.33% of 477
companies
in the Healthcare Providers & Services industry
Industry Median: 15.75
vs BOM:526783: 24.63
Dr Agarwal'S Eye Hospital (BOM:526783) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Dr Agarwal'S Eye Hospital's Enterprise Value for the quarter that ended in Jun. 2026 was ₹24,648 Mil.
Dr Agarwal'S Eye Hospital's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1,119 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr Agarwal'S Eye Hospital EV-to-EBIT Related Terms
Dr Agarwal'S Eye Hospital EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:526783 vs HCA, THC, DVA: EV-to-EBIT Comparison
For the Medical Care Facilities subindustry, Dr Agarwal'S Eye Hospital's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr Agarwal'S Eye Hospital EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dr Agarwal'S Eye Hospital's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Dr Agarwal'S Eye Hospital's EV-to-EBIT falls into.
Dr Agarwal'S Eye Hospital's current Enterprise Value is ₹27,556 Mil.
Dr Agarwal'S Eye Hospital's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1,119 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr Agarwal'S Eye Hospital (BOM:526783) has a EV-to-EBIT of 24.63 as of Aug. 30, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Dr Agarwal'S Eye Hospital and its competitors. This is 69% above median its historical median of 14.57. Over the past decade, Dr Agarwal'S Eye Hospital's EV-to-EBIT has ranged from 3.44 to 45.08. According to the industry distribution chart, Dr Agarwal'S Eye Hospital ranks #345 out of 477 companies in the Healthcare Providers & Services industry, placing it in the top 72.3%.
Is Dr Agarwal'S Eye Hospital's EV-to-EBIT too high?
Dr Agarwal'S Eye Hospital's current EV-to-EBIT of 24.63 is 69% above median its 10-year median of 14.57. Over the past 10 years, this metric has ranged from a low of 3.44 to a high of 45.08. The Healthcare Providers & Services industry median EV-to-EBIT is 15.75. Dr Agarwal'S Eye Hospital's value of 24.63 is 56.4% above this industry median. Based on the distribution chart, Dr Agarwal'S Eye Hospital ranks #345 out of 477 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Dr Agarwal'S Eye Hospital has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Dr Agarwal'S Eye Hospital's EV-to-EBIT compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Dr Agarwal'S Eye Hospital ranks #345 out of 477 companies for EV-to-EBIT. This places Dr Agarwal'S Eye Hospital in the lower half of its industry. The industry median EV-to-EBIT is 15.75. Dr Agarwal'S Eye Hospital's value of 24.63 is 56.4% above this benchmark. Historically, Dr Agarwal'S Eye Hospital's own EV-to-EBIT has ranged from 3.44 to 45.08 over the past decade. While the company's 10-year median is 14.57 vs. the industry median of 15.75, Dr Agarwal'S Eye Hospital has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.75, based on 477 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dr Agarwal'S Eye Hospital's current EV-to-EBIT of 24.63 is 56.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Dr Agarwal'S Eye Hospital and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dr Agarwal'S Eye Hospital's current EV-to-EBIT is 24.63, which is 69% above median its own 10-year median of 14.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr Agarwal'S Eye Hospital stock overvalued right now?
Based on GuruFocus' analysis, Dr Agarwal'S Eye Hospital (BOM:526783) is currently considered Fairly Valued. The stock's GF Value™ is ₹5,531.87, compared to a current price of ₹5,224.95 — trading 5.5% below its estimated fair value. The current EV-to-EBIT is 24.63, which is 69% above median its 10-year median of 14.57 and 56.4% above the Healthcare Providers & Services industry median of 15.75. Dr Agarwal'S Eye Hospital's overall GF Score™ is 94/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Dr Agarwal'S Eye Hospital (BOM:526783), the current EV-to-EBIT is 24.63 as of Aug. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dr Agarwal'S Eye Hospital (BOM:526783) Overvalued in 2026?
Based on GuruFocus' analysis, Dr Agarwal'S Eye Hospital stock appears to be undervalued.
The current stock price of ₹5,224.95 is trading 5.5% below its estimated GF Value™ of ₹5,531.87.
GuruFocus considers Dr Agarwal'S Eye Hospital to be Fairly Valued.
Key valuation signals for BOM:526783:
EV-to-EBIT: 24.63 (69% above median its 10-year median of 14.57)
GF Value™: ₹5,531.87 vs. price of ₹5,224.95 (5.5% below fair value)
Industry Position: 56.4% above the Healthcare Providers & Services median (#345 of 477)
No single metric tells the full story. See the BOM:526783 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dr Agarwal'S Eye Hospital Ltd is a provider of eye care and related services. The company is predominantly engaged in running, owning and managing eye care hospitals, opticals, pharmacies, and related services. It operates across various locations in India and provides solutions like Refractive Surgery, Lasik Surgery, Oculoplasty, Laser Cataract Surgery, and SMILE Eye Surgery among others.
94GF Score
Get the complete analysis for BOM:526783
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:526783 has been successfully added to your 
